Omata M - Search Results

1

Progression from chronic hepatitis to hepatocellular carcinoma: natural course and treatments.

Omata M, Yoshida H, Shiratori Y, Shiina S. Omata M, et al. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S434-6. doi: 10.1046/j.1440-1746.17.s3.41.x. J Gastroenterol Hepatol. 2002. PMID: 12472977 Review. No abstract available.

2

Risk factors for esophageal variceal bleeding in patients with hepatocellular carcinoma.

Akanuma M, Yoshida H, Okamoto M, Ogura K, Maeda S, Hata Y, Sato S, Shiina S, Kawabe T, Shiratori Y, Omata M. Akanuma M, et al. Among authors: omata m. Hepatogastroenterology. 2002 Jul-Aug;49(46):1039-44. Hepatogastroenterology. 2002. PMID: 12143197

3

Interferon therapy prolonged life expectancy among chronic hepatitis C patients.

Yoshida H, Arakawa Y, Sata M, Nishiguchi S, Yano M, Fujiyama S, Yamada G, Yokosuka O, Shiratori Y, Omata M. Yoshida H, et al. Among authors: omata m. Gastroenterology. 2002 Aug;123(2):483-91. doi: 10.1053/gast.2002.34785. Gastroenterology. 2002. PMID: 12145802

4

Hepatocellular carcinoma in elderly patients: beneficial therapeutic efficacy using percutaneous ethanol injection therapy.

Teratani T, Ishikawa T, Shiratori Y, Shiina S, Yoshida H, Imamura M, Obi S, Sato S, Hamamura K, Omata M. Teratani T, et al. Among authors: omata m. Cancer. 2002 Aug 15;95(4):816-23. doi: 10.1002/cncr.10735. Cancer. 2002. PMID: 12209726 Free article. Clinical Trial.

5

Cost-effectiveness of adjuvant interferon therapy after surgical resection of Hepatitis C-related hepatocellular carcinoma.

Hoshida Y, Shiratori Y, Omata M. Hoshida Y, et al. Among authors: omata m. Liver. 2002 Dec;22(6):479-85. doi: 10.1034/j.1600-0676.2002.01736.x. Liver. 2002. PMID: 12445173

6

Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.

Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, Goto T, Moriyama M, Otsuka M, Shiina S, Shiratori Y, Ito Y, Omata M. Wang Y, et al. Among authors: omata m. Hepatology. 2003 Jan;37(1):65-71. doi: 10.1053/jhep.2003.50017. Hepatology. 2003. PMID: 12500190

7

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus.

Shiratori Y, Shiina S, Teratani T, Imamura M, Obi S, Sato S, Koike Y, Yoshida H, Omata M. Shiratori Y, et al. Among authors: omata m. Ann Intern Med. 2003 Feb 18;138(4):299-306. doi: 10.7326/0003-4819-138-4-200302180-00008. Ann Intern Med. 2003. PMID: 12585827 Clinical Trial.

8

[HCV-related hepatocellular carcinoma].

Otsuka M, Kato N, Yoshida H, Yoshida H, Shiratori Y, Omata M. Otsuka M, et al. Among authors: omata m. Uirusu. 2002 Dec;52(2):295-300. Uirusu. 2002. PMID: 12685322 Free article. Review. Japanese. No abstract available.

9

Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.

Koike Y, Nakagawa K, Shiratori Y, Shiina S, Imamura M, Sato S, Obi S, Teratani T, Hamamura K, Yoshida H, Omata M. Koike Y, et al. Among authors: omata m. Hepatogastroenterology. 2003 Nov-Dec;50(54):2035-9. Hepatogastroenterology. 2003. PMID: 14696460

10

Prevention and treatment of hepatocellular carcinoma.

Omata M, Yoshida H. Omata M, et al. Liver Transpl. 2004 Feb;10(2 Suppl 1):S111-4. doi: 10.1002/lt.20046. Liver Transpl. 2004. PMID: 14762850 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,294 results

Search Page

Filters